A detailed history of Planning Capital Management Corp transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 8 shares of APLT stock, worth $76. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 5 60.0%
Holding current value
$76
Previous $24,000 183.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$4.35 - $8.5 $13 - $25
3 Added 60.0%
8 $68,000
Q2 2024

Aug 12, 2024

BUY
$4.04 - $6.37 $20 - $31
5 New
5 $24,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $462M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.